Myo-inositol alters C-labelled fatty acid metabolism in human placental explants
Myo-inositol alters C-labelled fatty acid metabolism in human placental explants
We postulate that myo-inositol, a proposed intervention for gestational-diabetes, affects transplacental lipid supply to the fetus. We investigated the effect of myo-inositol on fatty-acid processing in human placental-explants from uncomplicated pregnancies. Explants were incubated with 13C-labeled palmitic-acid, 13C-oleic-acid and 13C-docosahexaenoic-acid across a range of myo-inositol concentrations for 24 h and 48 h. The incorporation of labeled-fatty-acids into individual lipids was quantified by liquid-chromatography-mass-spectrometry. At 24 h, myo-inositol increased the amount of 13C-palmitic-acid and 13C-oleic-acid labeled lipids (median fold-change relative to control=1). Significant effects were seen with 30 µM myo-inositol (physiological) for 13C-palmitic-acid-lysophosphatidylcholines (1.26) and 13C-palmitic-acid-phosphatidylethanolamines (1.17). At 48 h, myo-inositol addition increased 13C-oleic-acid-lipids but decreased 13C-palmitic-acid and 13C-docosahexaenoic-acid lipids. Significant effects were seen with 30 µM myo-inositol for 13C-oleic-acid-phosphatidylcholines (1.25), 13C-oleic-acid-phosphatidylethanolamines (1.37) and 13C-oleic-acid-triacylglycerols (1.32) and with 100 µM myo-inositol for 13C-docosahexaenoic-acid-triacylglycerols (0.78). Lipids labeled with the same 13C-fatty-acid showed similar responses when tested at the same time-point, suggesting myo-inositol alters upstream processes such as fatty-acid uptake or activation. Myo-inositol supplementation may alter placental lipid physiology with unknown clinical consequences.
73-84
Watkins, Oliver C.
985df9b8-72d6-4f32-9ee3-54553c990fdc
Islam, Mohammed Omedul
15ef9293-6460-405f-8c04-40d14a9d3f5e
Selvam, Preben
989ffd8a-e214-43b5-a3ce-a814fc491ee7
Pillai, Reshma Appukuttan
c6a8a2d9-eaa1-4963-8c2c-5aed5d7e0503
Cazenave-Gassiot, Amaury
f53d5438-9fad-4fd6-98f9-3e289205dcd7
Bendt, Anne K.
3a269eb1-2755-4020-a6a1-12100ae89bd4
Karmani, Neerja
e1e6a7bb-c0d0-42ac-b740-429fa3895b43
Godfrey, Keith
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Lewis, Rohan
caaeb97d-ea69-4f7b-8adb-5fa25e2d3502
Wenk, Markus R.
d1ba356f-b0ed-4318-886a-c8f929679060
Chan, Shiao-Yng
3c9d8970-2cc4-430a-86a7-96f6029a5293
October 2019
Watkins, Oliver C.
985df9b8-72d6-4f32-9ee3-54553c990fdc
Islam, Mohammed Omedul
15ef9293-6460-405f-8c04-40d14a9d3f5e
Selvam, Preben
989ffd8a-e214-43b5-a3ce-a814fc491ee7
Pillai, Reshma Appukuttan
c6a8a2d9-eaa1-4963-8c2c-5aed5d7e0503
Cazenave-Gassiot, Amaury
f53d5438-9fad-4fd6-98f9-3e289205dcd7
Bendt, Anne K.
3a269eb1-2755-4020-a6a1-12100ae89bd4
Karmani, Neerja
e1e6a7bb-c0d0-42ac-b740-429fa3895b43
Godfrey, Keith
0931701e-fe2c-44b5-8f0d-ec5c7477a6fd
Lewis, Rohan
caaeb97d-ea69-4f7b-8adb-5fa25e2d3502
Wenk, Markus R.
d1ba356f-b0ed-4318-886a-c8f929679060
Chan, Shiao-Yng
3c9d8970-2cc4-430a-86a7-96f6029a5293
Watkins, Oliver C., Islam, Mohammed Omedul, Selvam, Preben, Pillai, Reshma Appukuttan, Cazenave-Gassiot, Amaury, Bendt, Anne K., Karmani, Neerja, Godfrey, Keith, Lewis, Rohan, Wenk, Markus R. and Chan, Shiao-Yng
(2019)
Myo-inositol alters C-labelled fatty acid metabolism in human placental explants.
Journal of Endocrinology, 243 (1), .
(doi:10.1530/JOE-19-0267).
Abstract
We postulate that myo-inositol, a proposed intervention for gestational-diabetes, affects transplacental lipid supply to the fetus. We investigated the effect of myo-inositol on fatty-acid processing in human placental-explants from uncomplicated pregnancies. Explants were incubated with 13C-labeled palmitic-acid, 13C-oleic-acid and 13C-docosahexaenoic-acid across a range of myo-inositol concentrations for 24 h and 48 h. The incorporation of labeled-fatty-acids into individual lipids was quantified by liquid-chromatography-mass-spectrometry. At 24 h, myo-inositol increased the amount of 13C-palmitic-acid and 13C-oleic-acid labeled lipids (median fold-change relative to control=1). Significant effects were seen with 30 µM myo-inositol (physiological) for 13C-palmitic-acid-lysophosphatidylcholines (1.26) and 13C-palmitic-acid-phosphatidylethanolamines (1.17). At 48 h, myo-inositol addition increased 13C-oleic-acid-lipids but decreased 13C-palmitic-acid and 13C-docosahexaenoic-acid lipids. Significant effects were seen with 30 µM myo-inositol for 13C-oleic-acid-phosphatidylcholines (1.25), 13C-oleic-acid-phosphatidylethanolamines (1.37) and 13C-oleic-acid-triacylglycerols (1.32) and with 100 µM myo-inositol for 13C-docosahexaenoic-acid-triacylglycerols (0.78). Lipids labeled with the same 13C-fatty-acid showed similar responses when tested at the same time-point, suggesting myo-inositol alters upstream processes such as fatty-acid uptake or activation. Myo-inositol supplementation may alter placental lipid physiology with unknown clinical consequences.
Text
Myo-inositol alters placental lipid metabolism_J_Endo_ 17_7_19_ clean
- Accepted Manuscript
More information
Accepted/In Press date: 12 August 2019
e-pub ahead of print date: 12 August 2019
Published date: October 2019
Identifiers
Local EPrints ID: 433883
URI: http://eprints.soton.ac.uk/id/eprint/433883
ISSN: 0022-0795
PURE UUID: 21dfbf63-4624-4503-964f-df4277f82a92
Catalogue record
Date deposited: 05 Sep 2019 16:30
Last modified: 17 Mar 2024 02:53
Export record
Altmetrics
Contributors
Author:
Oliver C. Watkins
Author:
Mohammed Omedul Islam
Author:
Preben Selvam
Author:
Reshma Appukuttan Pillai
Author:
Amaury Cazenave-Gassiot
Author:
Anne K. Bendt
Author:
Neerja Karmani
Author:
Markus R. Wenk
Author:
Shiao-Yng Chan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics